Non-surgical management of erectile dysfunction

被引:17
作者
Levy, A
Crowley, T
Gingell, C
机构
[1] Univ Bristol, Bristol Royal Infirm, Div Med, Res Ctr Neuroendocrinol, Bristol BS2 8HW, Avon, England
[2] Southmead Hosp, Dept Urol, Bristol Urol Inst, Bristol, Avon, England
关键词
D O I
10.1046/j.1365-2265.2000.00954.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Erectile dysfunction is a common and distressing medical condition that is now highly amenable to treatment almost irrespective of the cause. Safe, non-surgical treatments with unequivocal efficacy are psychological therapy, intracorporeal injection of vasoactive drugs, transurethral vasodilators and oral sildenafil, all of which have been reported to have a 50-70% overall response rate. Vacuum constriction devices are acceptable for some, usually older patients and oral yohimbine is thought to have marginal efficacy. Local creams to induce or enhance erectile function are currently being investigated. There is no place for androgen supplementation unless the patient is profoundly hypogonadal. Treatment of hyperprolactinaemia is very effective but is a rare cause of erectile dysfunction. As intercourse may entail an unfamiliar level of physical activity, it is sensible to ensure that the patient is able to climb a flight or two of stairs comfortably without provoking undue breathlessness or chest pain and to provide suitable advice about technique before commencing treatment. Once it is clear to the patients that erectile dysfunction can be satisfactorily overcome, the long- term use of treatments to do so tends to wane. Thus, although the prospect of effective treatment for what had been for many a distressing life sentence has the potential to place new demands on the health service, there is no evidence that restrictions on prescribing will prove economically rational.
引用
收藏
页码:253 / 260
页数:8
相关论文
共 105 条
[31]   Yohimbine for erectile dysfunction: A systematic review and meta-analysis of randomized clinical trials [J].
Ernst, E ;
Pittler, MH .
JOURNAL OF UROLOGY, 1998, 159 (02) :433-436
[32]  
FALLON B, 1995, UROL CLIN N AM, V22, P833
[33]   IMPOTENCE AND ITS MEDICAL AND PSYCHOSOCIAL CORRELATES - RESULTS OF THE MASSACHUSETTS MALE AGING STUDY [J].
FELDMAN, HA ;
GOLDSTEIN, I ;
HATZICHRISTOU, DG ;
KRANE, RJ ;
MCKINLAY, JB .
JOURNAL OF UROLOGY, 1994, 151 (01) :54-61
[34]   Unusual complications of the vacuum erection device [J].
Ganem, JP ;
Lucey, DT ;
Janosko, EO ;
Carson, CC .
UROLOGY, 1998, 51 (04) :627-631
[35]   INTRACAVERNOUS SELF-INJECTION WITH VASOACTIVE INTESTINAL POLYPEPTIDE AND PHENTOLAMINE IN THE MANAGEMENT OF ERECTILE FAILURE [J].
GERSTENBERG, TC ;
METZ, P ;
OTTESEN, B ;
FAHRENKRUG, J .
JOURNAL OF UROLOGY, 1992, 147 (05) :1277-1279
[36]   VACUUM CONSTRICTION DEVICES - 2ND-LINE CONSERVATIVE TREATMENT FOR IMPOTENCE [J].
GILBERT, HW ;
GINGELL, JC .
BRITISH JOURNAL OF UROLOGY, 1992, 70 (01) :81-83
[37]  
Gingell C, 1998, HOSP MED, V59, P777
[38]  
Gingell JC, 1998, BRIT J UROL, V81, P599
[39]   Oral sildenafil in the treatment of erectile dysfunction [J].
Goldstein, I ;
Lue, TF ;
Padma-Nathan, H ;
Rosen, RC ;
Steers, WD ;
Wicker, PA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) :1397-1404
[40]   ANDROGEN LEVELS AND SEX FUNCTIONS IN TESTOSTERONE-TREATED HYPOGONADAL MEN [J].
GOOREN, LJG .
ARCHIVES OF SEXUAL BEHAVIOR, 1987, 16 (06) :463-473